Preclinical studies showed that in combination with conventional anticancer drugs, ferroptosis inducers are effective in prostate cancer and in combating the progression towards the castration resistant disease. The authors review the mechanisms implicated in ferroptosis and discuss the findings achieved in prostate cancer.
[Current Medicinal Chemistry]
Sorry, but the selected Zotpress account can't be found.
